Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab

E Yao, W Zhou, S. T Lee Hoeflich, T Truong, P. M Haverty, J Eastham Anderson, N Lewin Koh, B Gunter, M Belvin, L. J Murray, L. S Friedman, M. X Sliwkowski and K. P. Hoeflich

Clinical Cancer Research 15 ( 12 ): 4147 - 4156 , 2009